Found 275 clinical trials
Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type
To evaluate the superiority of brexpiprazole 1 mg or 2 mg over placebo after a 10-week treatment regimen for agitation associated with dementia of the Alzheimer's type in patients who require
- 8 views
- 20 Jul, 2022
- 1 location
Treat-and-extend Using Aflibercept for Type 3 Neovascularization
-used, effective anti-vascular endothelial growth factor treatment regimen for neovascular AMD, regardless of subtypes of AMD. The purpose of the present study is to investigate the 18-month treatment
- 0 views
- 04 Mar, 2021
- 1 location
PDN Post Market, Multicenter, Prospective, Global Clinical Study (PDN-PM)
diabetic neuropathy (PDN). This is a multicenter, prospective, observational global study, that will partner diabetes management teams with pain physicians to provide an interdisciplinary treatment regimen
- 0 views
- 08 Jul, 2022
- 3 locations
SENSE Study: Remote Symptom Monitoring for Patients With Chemotherapy-induced Peripheral Neuropathy (SENSE)
, docetaxel, oxaliplatin or cisplatin) as part of their treatment regimen for cancer at-risk for falling. The investigators believe that by specifying early CIPN symptoms that predict fall-risk, The
- 0 views
- 01 May, 2022
- 1 location
Comparison of Efficacy of Triple Regimen Based on Clarithromycin VS Metronidazole in Children
, group A and group B randomly based on treatment regimen offered. Group A: Amoxicillin AMO + Clarithromycin CLA + Proton pump inhibitor PPI) Group B: Amoxicillin AMO+ Metronidazole MET+ Proton
- 6 views
- 28 Jan, 2021
- 2 locations
Bisantrene Combination for Resistant AML
tolerability of the combination regimen Time to response with combination treatment Overall survival The treatment regimen will comprise daily IV infusion of Fludarabine (Flu
- 0 views
- 30 Sep, 2021
- 1 location
Trichloroacetic Acid as a Topical Treatment for Actinic Cheilitis
many studies have compared treatment options for actinic cheilitis, there is still significant debate over how to best manage this condition. The chosen treatment regimen must result in complete
- 0 views
- 22 Aug, 2021
- 1 location
Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy
receiving previous second-line or above multidrug combination therapy, to study the efficacy and safety of the treatment regimen.
- 0 views
- 13 Jun, 2022
- 1 location
Treatment of Advanced and Metastatic Solid Tumors With MIL97
/kg Q3W). Duration of dose limiting toxicity (DLT) observation is 21 days. Based on data of 3-week treatment regimen, one or two dose levels may be chosen for Q2w regimen. Duration of dose limiting
- 0 views
- 18 Jun, 2022
- 1 location
Immune Checkpoint Inhibitor PD-1 Antibody Combined With Chemotherapy in the Perioperative Treatment of Locally Advanced Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
The FOLFIRINOX regimen has become the standard treatment regimen for advanced colorectal cancer, advanced pancreatic cancer and postoperative adjuvant treatment for pancreatic cancer. With the
- 1 views
- 09 Jun, 2021
- 1 location